Literature DB >> 25985906

Reply to Dunning.

Peter B Gilbert1, Erin E Gabriel2, Michael G Hudgens3, Xiaopeng Miao4, Xiaoming Li5, Shu-Chih Su6, Janie Parrino6, Ivan S F Chan6.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25985906      PMCID： PMC4612359          DOI： 10.1093/infdis/jiv287

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Augmented designs to assess immune response in vaccine trials.

Authors:  Dean Follmann
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

2.  Surrogates of protection in repeated low-dose challenge experiments.

Authors:  Dustin M Long; Michael G Hudgens; Chih-Da Wu
Journal:  Stat Med       Date:  2015-01-28       Impact factor: 2.373

3.  The prevention and treatment of missing data in clinical trials.

Authors:  Roderick J Little; Ralph D'Agostino; Michael L Cohen; Kay Dickersin; Scott S Emerson; John T Farrar; Constantine Frangakis; Joseph W Hogan; Geert Molenberghs; Susan A Murphy; James D Neaton; Andrea Rotnitzky; Daniel Scharfstein; Weichung J Shih; Jay P Siegel; Hal Stern
Journal:  N Engl J Med       Date:  2012-10-04       Impact factor: 91.245

4.  Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.

Authors:  Peter B Gilbert; Erin E Gabriel; Xiaopeng Miao; Xiaoming Li; Shu-Chih Su; Janie Parrino; Ivan S F Chan
Journal:  J Infect Dis       Date:  2014-05-13       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.